Persistent diabetes and ketoacidosis due to L-asparaginase therapy.
D000138:Acidosis / Q000097:blood / Q000139:chemically induced*; D000941:Antigens; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local; D012075:Remission, Spontaneous
D000941:Antigens; D001786:Blood Glucose; D007328:Insulin; D001215:Asparaginase